| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/06/2015 | CA2753698C Methods and compositions for inhibiting cellular proliferation and surgical adhesion |
| 01/06/2015 | CA2749205C The synthesis of naturally occurring ecteinascidins and related compounds |
| 01/06/2015 | CA2737543C Composite organic compound powder for medical use and production method and suspension of the same |
| 01/06/2015 | CA2730154C The application of potassium 2-(1-hydroxypentyl)-benzoate (d1-phpb) for the prevention and treatment of alzheimer's disease |
| 01/06/2015 | CA2694621C Novel serotonergic modulators |
| 01/06/2015 | CA2688614C Phenyl-butoxy-phenyl-ethynyl substituted indole compounds having cyslt1/cyslt2 receptor antagonistic activity |
| 01/06/2015 | CA2663376C N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 01/06/2015 | CA2661105C Pyridin-4-yl derivatives as immunomodulating agents |
| 01/06/2015 | CA2657956C Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
| 01/06/2015 | CA2631289C The use of bacillus pb6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases |
| 01/06/2015 | CA2620612C Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
| 01/06/2015 | CA2619660C Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 01/06/2015 | CA2618807C Methods and devices for lymphatic targeting |
| 01/06/2015 | CA2617103C Macrocyclic inhibitors of hepatitis c virus |
| 01/06/2015 | CA2612599C Precursor compounds to antiarrhythmic benzolfuran compounds, methods of synthesis and methods of use |
| 01/06/2015 | CA2610795C 3-arylidene-anabaseine compounds as alpha 7 nicotitnic receptor selective ligands |
| 01/06/2015 | CA2606708C Thiadiazole mitotic kinesin inhibitors and methods of use thereof |
| 01/06/2015 | CA2606279C Crystalline solid and amorphous forms of (-)- halofenate and methods related thereto |
| 01/06/2015 | CA2596355C Tumor necrosis factor inhibitors |
| 01/06/2015 | CA2585797C Lactam compounds and their use as pharmaceuticals |
| 01/06/2015 | CA2562035C Treatment of depressive disorders |
| 01/06/2015 | CA2542913C Oligopeptides as coating material for medical products |
| 01/06/2015 | CA2525684C Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors |
| 01/06/2015 | CA2446083C Composition and methods for treatment of hyperplasia |
| 01/05/2015 | CA2856014A1 Combined use of amides of mono- and dicarboxylic acids and silymarin in the treatment of renal diseases |
| 01/01/2015 | US20150005519 Pharmaceutical compositions and methods of use of 4-pregenen-11beta-17-21-triol-3,20-dione derivatives |
| 01/01/2015 | US20150005506 Therapeutic agent for diabetes |
| 01/01/2015 | US20150005487 Sorbent comprising on its surface a cationic or protonizable aliphatic residue for the purification of organic molecules |
| 01/01/2015 | US20150005485 Synthetic heparin pentasaccharides |
| 01/01/2015 | US20150005391 Method of reducing scarring |
| 01/01/2015 | US20150005390 Method for treating inflammatory disorder |
| 01/01/2015 | US20150005388 Emesis treatment |
| 01/01/2015 | US20150005387 Composition containing agmatine, and uses thereof in preparing drugs or neutraceutical substances |
| 01/01/2015 | US20150005386 Methods of Reducing Risk of Cardiovascular Disease |
| 01/01/2015 | US20150005382 Methods for Identifying and Treating an Individual with an Inflammatory Disease using Fatty Acid-Based Therapies |
| 01/01/2015 | US20150005380 Gelling Formulation Based On Calcium Gluconate |
| 01/01/2015 | US20150005376 Concentrate esmolol |
| 01/01/2015 | US20150005374 Compounds and methods for delivery of prostacyclin analogs |
| 01/01/2015 | US20150005373 Method of Treating Acne |
| 01/01/2015 | US20150005372 Compositions and methods of altering cholesterol levels |
| 01/01/2015 | US20150005361 Induced pluripotent stem cell model of chronic myeloid leukemia revealed olfactomedin 4 as a novel therapeutic target in leukemia stem cells |
| 01/01/2015 | US20150005360 Phytoestrogen compositions and associated methods |
| 01/01/2015 | US20150005359 Novel combinations and methods |
| 01/01/2015 | US20150005356 Intranasal Formulation of Epinephrine for the Treatment of Anaphylaxis |
| 01/01/2015 | US20150005355 Combination therapy with parp inhibitors |
| 01/01/2015 | US20150005354 Combination Therapy With Parp Inhibitors |
| 01/01/2015 | US20150005351 Methods and kits for determining risk for developing alzheimer's disease and prevention or treatment thereof |
| 01/01/2015 | US20150005350 Administration of ethyl 3-[(2--1-methyl-1h-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionate |
| 01/01/2015 | US20150005344 Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl-6-Fluoro-2-(1-Hydroxy-2-Methylpropan-2-yl)-1H-lndol-5-yl)-Cyclopropanecarboxamide |
| 01/01/2015 | US20150005343 Use of eribulin and lenvatinib as combination therapy for treatment of cancer |
| 01/01/2015 | US20150005342 Hepatitis C Virus Inhibitors |
| 01/01/2015 | US20150005341 Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same |
| 01/01/2015 | US20150005339 Tris(hydroxymethyl)Aminomethane Salts of a Small-Molecule GLP1R Agonist and Pharmaceutical Compositions and Uses Thereof |
| 01/01/2015 | US20150005337 Transdermal Delivery Of Systemically Active Central Nervous System Drugs |
| 01/01/2015 | US20150005336 Opioid agonist/opioid antagonist/acetaminophen combinations |
| 01/01/2015 | US20150005335 Matrix for sustained, invariant and independent release of active compounds |
| 01/01/2015 | US20150005334 Abuse deterrent compositions and methods of use |
| 01/01/2015 | US20150005333 Pharmaceutical Formulation Containing Gelling Agent |
| 01/01/2015 | US20150005332 Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| 01/01/2015 | US20150005331 Pharmaceutical Formulation Containing Gelling Agent |
| 01/01/2015 | US20150005329 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group |
| 01/01/2015 | US20150005328 Oximes For Treatment Of Peripheral And Central Nervous System Exposure to Acetyl Cholinesterase Inhibitors |
| 01/01/2015 | US20150005327 Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer |
| 01/01/2015 | US20150005325 Drug Combinations and Uses in Treating a Coughing Condition |
| 01/01/2015 | US20150005324 Famciclovir for the Treatment of Recurrent Herpes Labialis Using a One-Day Treatment |
| 01/01/2015 | US20150005323 Sustained delivery formulations of risperidone compounds |
| 01/01/2015 | US20150005320 Compounds for inflammation and immune-related uses |
| 01/01/2015 | US20150005318 1-[2-(2,4-Dimethylphenylsulfanyl)-Phenyl]Piperazine As A Compound With Combined Serotonin Reuptake, 5-HT3 And 5-HT1a Activity For The Treatment Of Cognitive Impairment |
| 01/01/2015 | US20150005317 Mcl-1 as a therapeutic target in scffbw7 deficient neoplasm |
| 01/01/2015 | US20150005314 Pharmaceutical preparation comprising brexpirazole and substituted beta-cyclodextrin |
| 01/01/2015 | US20150005312 Compositions containing alpha-2-adrenergic agonist components |
| 01/01/2015 | US20150005308 Novel heteroarylamide derivatives having antiandrogenic properties |
| 01/01/2015 | US20150005307 Drug Delivery Technology |
| 01/01/2015 | US20150005306 Pharmaceutical composition for preventing or treating cognitive impairment-related disease comprising morpholine or piperazine based compounds, and donepezil |
| 01/01/2015 | US20150005303 5-substituted isoindoline compounds |
| 01/01/2015 | US20150005300 Pyridazinone compounds and methods for the treatment of cystic fibrosis |
| 01/01/2015 | US20150005297 2,4-Pyrimidinediamine Compounds and Their Uses |
| 01/01/2015 | US20150005295 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b |
| 01/01/2015 | US20150005294 Azaheterocyclic compounds |
| 01/01/2015 | US20150005292 Method and composition for treating alzheimer-type dementia |
| 01/01/2015 | US20150005291 Compositions for Increasing Hair Growth |
| 01/01/2015 | US20150005290 Compositions and methods for diagnosing and treating salt sensitivity of blood pressure |
| 01/01/2015 | US20150005288 Substituted phenylimidazopyrazoles and use thereof |
| 01/01/2015 | US20150005284 Furo[3,2-b]- and thieno[3,2-b]pyridin derivatives |
| 01/01/2015 | US20150005278 Sulfoximine substituted quinazolines for pharmaceutical compositions |
| 01/01/2015 | US20150005277 Protein Kinase Inhibitors and Uses Thereof |
| 01/01/2015 | US20150005273 Use of avocado skin for obtaining an avocado unsaponifiable material enriched with saturated aliphatic hydrocarbons and with sterols |
| 01/01/2015 | US20150005272 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 01/01/2015 | US20150005271 Controlled release delivery system for nasal applications and method of treatment |
| 01/01/2015 | US20150005270 Compositions for the treatment of gastrointestinal inflammation |
| 01/01/2015 | US20150005269 Treatment of Heart Failure and Sudden Cardiac Death |
| 01/01/2015 | US20150005268 Methods and compositions for treating cancer |
| 01/01/2015 | US20150005267 Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods |
| 01/01/2015 | US20150005266 Topical compositions for treatment of skin conditions |
| 01/01/2015 | US20150005265 Methods and compositions for combination therapy using p13k/mtor inhibitores |
| 01/01/2015 | US20150005263 Administration of hypoxia activated prodrugs in combination with chk1 inhibitors for treating cancer |
| 01/01/2015 | US20150005262 Hypoxia activated prodrugs and mtor inhibitors for treating cancer |
| 01/01/2015 | US20150005254 Methods for treating ocular inflammatory disorders |
| 01/01/2015 | US20150005253 Novel combinations for treating acute myeloid leukaemia or chronic myeloid leukaemia |
| 01/01/2015 | US20150005252 Combination therapy for the treatment of cancer |